Proton pump inhibitors and their drug interactions : an evidence-based approach

The proton pump inhibitors (PPIs) are the most effective antisecretory agents used to treat acid-related disorders. As such, they are frequently prescribed for patients who are concurrently using other medications. PPIs may interact with other drugs through numerous mechanisms. The most important in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of gastroenterology & hepatology 2001-05, Vol.13 (5), p.611-616
Hauptverfasser:	GERSON, Lauren B, TRIADAFILOPOULOS, George
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles Aryl Hydrocarbon Hydroxylases Benzimidazoles - pharmacology Biological and medical sciences Cytochrome P-450 CYP2C19 Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP3A Cytochrome P-450 Enzyme Inhibitors Drug Interactions Enzyme Inhibitors - pharmacology Gastrointestinal Agents - pharmacology General pharmacology Humans Lansoprazole Medical sciences Mixed Function Oxygenases - antagonists & inhibitors Omeprazole - analogs & derivatives Omeprazole - pharmacology Pantoprazole Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions Pharmacology. Drug treatments Proton Pump Inhibitors Rabeprazole Sulfoxides - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!